Switch to injectable compounded semaglutide
Landmark trials such as the UK Prospective Diabetes Study (UKPDS) [4], Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation (ADVANCE) [5], Action to Control Cardiovascular Risk in Diabetes (ACCORD) [6], and the Veterans Affairs Diabetes Trial (VADT) [7] convincingly demonstrated that tight glycemic control significantly reduced microvascular complications, particularly diabetic kidney disease
Research published in obesity and endocrinology journals shows average weight loss of 10-15% body weight over 12 months with semaglutide therapy, regardless of formulation source
According to a large US food demand survey (GLP-1use and protein demand, January 2026, Science Direct) looking into food-buying habits of GLP-1 users in January 2026, while users reported eating less food overall, they were willing to pay more for protein-rich, high-quality meat and seafood
Cherries: Natural Sweetness with GLP-1 Benefits Cherries contain polyphenols and fiber that help increase GLP-1 levels